Citinova P 500mg/800mg Tablet
By Citinova P
Rx
10 Tablet in a Strip

Composition
Citicoline(500mg) + Piracetam(800mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
September, 2027

liver
Citinova P 500mg/800mg Tablet is considered safe for patients with liver disease. The available data indicates that adjusting the dosage of Citinova P 500mg/800mg Tablet may not be necessary for individuals with liver conditions. It is recommended to consult your doctor if you have liver impairment or any related concerns before using this medication.

kidney
Citinova P 500mg/800mg Tablet should be used cautiously in patients with kidney disease. Dose adjustment may be necessary, especially for those with kidney impairment. It is not recommended for patients with severe kidney disease. Please consult your doctor for guidance.

alcohol
Caution Avoid alcohol with Citinova P 500mg/800mg Tablet Tablet as it may cause increased drowsiness. Consult your doctor.

driving
Caution should be taken when driving after taking Citinova P 500mg/800mg Tablet, as it may cause drowsiness, nervousness, and shakiness. These side effects could impair your focus and reaction time while driving. Avoid driving or operating machinery if affected.

pregnancy
It is better to consult your doctor before using Citinova P 500mg/800mg Tablet.

breastfeeding
It is better to consult your doctor before using Citinova P 500mg/800mg Tablet during breastfeeding, as there is no specific safety information available. Your doctor will determine if it is safe for breastfeeding mothers to take this medication.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹621.56
₹731.25
15% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
